Erratum

by The European Orgalutran® Study Group, G.Borm and B.Mannaerts

Treatment with gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

In the above paper, the order of the authors was given incorrectly in the Contents of the Journal. The correct order is given above.

The e-mail address given for the corresponding author on 1490 was given incorrectly. The correct e-mail address is: b.mannaerts{at}organon.oss.akzonobel.nl





This Article
Extract
FREE Full Text (PDF )
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Request Permissions
PubMed
PubMed Citation